当前位置: X-MOL 学术Nat. Rev. Cardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Novel cardiovascular therapeutics and the risk of financial toxicity
Nature Reviews Cardiology ( IF 49.6 ) Pub Date : 2024-03-14 , DOI: 10.1038/s41569-024-01010-4
Alexander H. Gunn , Akshay Pendyal

Novel cardiovascular therapeutics have the potential to improve health outcomes, but financial toxicity from high out-of-pocket costs can limit the reach of these medications and worsen existing health disparities. Understanding the phenomenon of financial toxicity in treating cardiovascular disease is crucial to achieving health equity.

中文翻译:

新型心血管疗法和财务毒性风险

新型心血管疗法有可能改善健康结果,但高额自付费用带来的经济毒性可能会限制这些药物的使用范围,并加剧现有的健康差距。了解治疗心血管疾病的经济毒性现象对于实现健康公平至关重要。
更新日期:2024-03-15
down
wechat
bug